The Collaborative Islet Transplantation Registry Program

by: Michael Saunders

The National Institutes of Health, more commonly referred to as NIH, is a federal government agency operating under the United States Department of Health and Human Services that's greatly accountable for financially supporting all of the nation's biomedical and health-related research studies.

The initiatives of the NIH are all specially designed to assist in the attainment of its primary agency mission which is "to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In accordance with this mission, the National Institutes of Health has formed a partnership with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in order to establish the The Collaborative Islet Transplantation Registry Program wherein both agencies seek to invite applications that intend to continue initiatives started through the Collaborative Islet Transplantation Registry (CITR).

The registry is comprised of substantial data regarding human islet transplantation experience from the year 1999 to present. The data also includes information concerning pancreas donors, islet preparations, transplantation procedures, associated therapies, and recipient outcomes.

The program in focus seeks to improve the availability and dissemination of these data to islet transplant centers, and the rest of the medical community.

  (continued...)

The Collaborative Islet Transplantation Registry Program
  Page 2

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program
In this capacity, the Food and Drug Administration has recently established the Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program in an attempt to study the effects of various physicochemical properties of ophthalmic suspensions and emulsions on ocular bioavailability.

---

Small Business Innovation Research Phase IIB Bridge Awards
In line with this mission, the NIH has recently constituted the Small Business Innovation Research Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization Program.

---

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
The National Institutes of Health, in cooperation with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies seek to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common goal of medications development.

---

Learning Disabilities Innovation Hubs Program
The National Institutes of Health has partnered with the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to establish the Learning Disabilities Innovation Hubs Program where both agencies intend to solicit resource-related research project grant applications that concentrate on the etiology, manifestation, prevention, and remediation of writing, reading, or mathematics learning disabilities.

---